Newsletter
Ep05: Prescription Digital Therapeutics with Pierre Leurent, CEO of Voluntis

DTx Podcast with Eugene Borukhovich

Ep05: Prescription Digital Therapeutics with Pierre Leurent, CEO of Voluntis

Plus: The very early days of DTx, starting the DTA and the benefits of going public and more
January 26, 2021

Ep05: Prescription Digital Therapeutics with Pierre Leurent, CEO of Voluntis

In this episode, we speak with one of the founding members of the Digital Therapeutics Alliance (‘DTA’), Pierre Leurent. Pierre is the CEO and founder of Voluntis, which is the first publicly listed DTx company on Euronext in Paris.

Pierre co-founded Voluntis in 2001 with the mission to improve patients’ experience with their treatment thanks to digital technologies. Now, 20 years later, they have supported more than 600,000 patients and deployed over 50 programs around the world.

Pierre is a Director of the Digital Therapeutics Alliance, of which he served as Chairman, and a member of Advamed’s Digital Health Executive Leadership Group. He previously co-chaired the digital therapeutics task force of the Personal Connected Health Alliance, a member of HIMSS, and chaired the eHealth France Alliance regrouping several leading trade organizations representing digital and life sciences companies in France. Pierre holds a MS from Ecole Centrale Paris.

Links and Resources:

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp